- Home
- HESM vs PTGX Comparison
HESM vs PTGX Comparison
Compare HESM & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HESM | PTGX |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.1B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | HESM | PTGX |
|---|---|---|
| Price | $35.99 | $82.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | $42.25 | ★ $93.00 |
| AVG Volume (30 Days) | ★ 1.3M | 788.9K |
| Earning Date | 02-02-2026 | 02-20-2026 |
| Dividend Yield | ★ 8.58% | N/A |
| EPS Growth | ★ 18.64 | N/A |
| EPS | ★ 2.81 | 0.72 |
| Revenue | ★ $1,613,000,000.00 | $209,217,000.00 |
| Revenue This Year | $11.67 | N/A |
| Revenue Next Year | N/A | $409.41 |
| P/E Ratio | ★ $12.69 | $115.35 |
| Revenue Growth | ★ 10.78 | N/A |
| 52 Week Low | $31.63 | $33.70 |
| 52 Week High | $44.14 | $96.54 |
Technical Indicators
Market Signals| Indicator | HESM | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 67.51 | 44.12 |
| Support Level | $35.02 | $81.94 |
| Resistance Level | $35.75 | $85.50 |
| Average True Range (ATR) | 0.59 | 3.16 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 91.58 | 40.39 |
Price Performance
Historical ComparisonAbout HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.